Update in cystic fibrosis 2009.
Mogayzel
Peter J
PJ
Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. pmogayze@jhmi.edu
Flume
Patrick A
PA
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001398:Aztreonam / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000235:genetics / Q000382:microbiology / Q000628:therapy*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016040:Lung Transplantation; D008403:Mass Screening / Q000379:methods; D011110:Polymorphism, Genetic / Q000235:genetics; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001398:Aztreonam